Stay updated on ASP1517 Oral Dosing in Anemia: Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Oral Dosing in Anemia: Clinical Trial page.

Latest updates to the ASP1517 Oral Dosing in Anemia: Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2, while the page continued to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now renders as a 403 Forbidden error, replacing the usual study content with an access-restricted message. The visible elements include the error header, a Home button, and the standard footer, indicating blocked access rather than a data update.SummaryDifference18%

- Check51 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing v3.6.5, indicating an internal update to the page template rather than a change to study information.SummaryDifference0.0%

- Check72 days agoChange DetectedIntroduces a new site revision label, v3.6.5, and removes several footer/branding elements, including the link to the Astellas Clinical Study Results site and related branding text.SummaryDifference0.2%

- Check86 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release.SummaryDifference0.0%

Stay in the know with updates to ASP1517 Oral Dosing in Anemia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Oral Dosing in Anemia: Clinical Trial page.